InvestorsHub Logo
Followers 11
Posts 2894
Boards Moderated 1
Alias Born 03/19/2007

Re: alertmeipp post# 8970

Thursday, 08/30/2007 5:01:54 PM

Thursday, August 30, 2007 5:01:54 PM

Post# of 51838
To alertmeipp, and OT to JimHaynes,

alertmeipp, I bought more cor this past week from 1.83 down to 1.75, maybe 4000 shares total.

OT: Jimhaynes In one of your recent posts you mentioned that you had done well with Onyx. I was wondering if you knew much about Scott M. Freeman from Onyx.

Below is from the Aug. 8th Wall St Journal Online.

HOLLIS-EDEN PHARMACEUTICALS Inc. (San Diego) -- Scott M. Freeman was named chief medical officer, a new position with this drug company. Dr. Freeman, 50, was vice president, clinical development and operations with Onyx Pharmaceuticals Inc.

I have been investing in HEPH all week as I believe they are in a rather heavy oversold position.

Yahoo reports that as of June 7, 2007, HEPH had no debt, 52 million in cash and approx 29 million shares out. That works out to approx 1.80 an outstanding share in CASH. The stock is trading at around 1.50 now.

Anyway, I was curious if you know much about Mr. Freeman from your reported good experience with Onyx.

Thanks for any insight you may be able to provide.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News